Although these studies characterize SETD3 as an oncoprotein, evidence demonstrates that high levels of SETD3 enhance the sensitization of cervical cancer cells to radiotherapy, potentially implicating SETD3 as a tumor suppressor [13]. This evidence concerns the gene SETD3 and cervical carcinoma.